|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/444 | |
| A61K 31/506 | |||
| A61K 31/55 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Patento numeris | 3442529 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17717990.0 |
| Europos patento paraiškos padavimo data | 2017-04-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/026134 |
| Data | 2017-04-05 |
| (87) | Numeris | WO 2017/180389 |
| Data | 2017-10-19 |
| (30) | Numeris | Data | Šalis |
| 201662321311 P | 2016-04-12 | US |
| (72) |
BECKMANN, Richard Paul, US
PATEL, Bharvin Kumar, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY WITH NOTCH AND CDK4/6 INHIBITORS FOR THE TREATMENT OF LUNG CANCER |
| COMBINATION THERAPY WITH NOTCH AND CDK4/6 INHIBITORS FOR THE TREATMENT OF LUNG CANCER |